Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Pfizer (U.K. Rights to 3 Products)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Portfolio of dermatology products. The portfolio consists of the following brands, the oral antihistamine Atarax, the oral steroid Deltacortril, and Terracortril, a topical combination steroid.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • England, United Kingdom

Pfizer (U.K. Rights to 3 Products) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Pfizer (U.K. Rights to 3 Products)‘s full profile, request access.

Request full access to PitchBook

Pfizer (U.K. Rights to 3 Products) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Pfizer (U.K. Rights to 3 Products)‘s full profile, request access.

Request full access to PitchBook